Enabling rapid, tag-free macrocycle library synthesis for agile, precision drug discovery with unmatched speed and chemical diversity.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
BRT Biotechnologies is a drug discovery company that accelerates the creation of macrocycle-based small molecule libraries using its proprietary BRiTeCycle™ platform—enabling rapid, tag-free synthesis of chemically rich, ready-to-screen compounds. It transforms early-stage screening by allowing researchers to access diverse, high-quality libraries at unmatched speed and flexibility for precision therapeutic lead identification.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
BRT Biotechnologies Management Team
BRT Biotechnologies Valuations & Financials
View real-time NPM data on BRT Biotechnologies stock including daily BRT Biotechnologies stock price estimates, valuation history, and historical share price information. Access BRT Biotechnologies financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track BRT Biotechnologies pricing across six independent market signals. Looking for private company due diligence data sources on BRT Biotechnologies? Get in touch to learn more.
Similar Companies
like BRT Biotechnologies
MORE Health
Healthcare & Life Sciences
Digital platform connects patients to medical experts worldwide for second opinions and specialized care guidance, improving health outcomes.
Elevian
Healthcare & Life Sciences
Develops regenerative medicines and protein therapies to enhance recovery after stroke and aging-related conditions by stimulating tissue repair.
Mozart Therapeutics
Healthcare & Life Sciences
Develops biologic therapies targeting CD8 Treg cells to restore immune system function and treat autoimmune diseases
Cajal Neuroscience
Healthcare & Life Sciences
Discovers drug targets for neurodegenerative diseases using advanced microscopy and genomics to develop treatments for brain disorders.
Ring Therapeutics
Healthcare & Life Sciences
Develops gene therapy treatments using natural anelloviruses to create targeted, reusable therapeutic solutions for various medical conditions.
Epic Bio
Healthcare & Life Sciences
Develops epigenetic engineering therapies to modulate gene expression without DNA modification, using compact CRISPR delivery systems.
AtaCor Medical
Healthcare & Life Sciences
Develops extravascular cardiac pacing and defibrillation technology to deliver safer, less invasive heart rhythm management solutions.
Calyxo
Healthcare & Life Sciences
Removes kidney stones using a steerable ureteroscopic treatment system combining laser, irrigation, and aspiration in one procedure.
OncoPrecision
Healthcare & Life Sciences
Develops screening technology to predict cancer patients' therapy responses quickly, improving treatment outcomes.
FAQ
We have answers
BRT Biotechnologies stock does not trade on public stock exchanges. BRT Biotechnologies stock is considered a private security and you need to be an accredited investor to trade shares. To invest in BRT Biotechnologies stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
BRT Biotechnologies Stock does not trade on public stock exchanges. In order to sell BRT Biotechnologies shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
BRT Biotechnologies does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view BRT Biotechnologies share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for BRT Biotechnologies stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell BRT Biotechnologies stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in BRT Biotechnologies stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
BRT Biotechnologies is a private company and has not had an IPO. There is currently no BRT Biotechnologies IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to BRT Biotechnologies IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
